Product Wiki · Recalls · EU Safety Gate (RAPEX)

MEGA STRONG CANNA MIX SATIVA — recall SR/01972/26

EU Safety Gate (RAPEX) · Czechia · 2026-07-10 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01972/26
Date of alert
2026-07-10
Country / jurisdiction
Czechia
Risk level
Serious risk
Risk type
Chemical
Brand
mySWAG
Product category
Chemical products
Product type
Herbal product for smoking
Barcode (EAN/GTIN)
0751784454052
🔴 Serious hazard — Reported risk: The product contains a psychoactive cannabinoid (MDMB-PINACA), which is a highly potential psychoactive substance acting on the central nervous system and can therefore cause mental and behavioural disorders. The use of this substance is associated with the risk of serious toxic effects, including acute intoxication, impaired consciousness, mental and behavioral disorders, neurological complications and cardiovascular effects.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Date of entry into force
21/05/2026
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10099407

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.